These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Animal study on radioactive antigenic fractions isolated from V.cholerae. I. The Ch 1 + 2 fraction]. Dodin A; Plawecki M Bull Soc Pathol Exot Filiales; 1978; 71(1):22-33. PubMed ID: 719845 [TBL] [Abstract][Full Text] [Related]
8. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. Liao J; Gibson JA; Pickering BS; Watnick PI mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145 [TBL] [Abstract][Full Text] [Related]
9. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model. Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination. Rijpkema SG; Jansen WH; Gielen H; Guinée PA Microb Pathog; 1987 Nov; 3(5):365-75. PubMed ID: 2462153 [TBL] [Abstract][Full Text] [Related]
11. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains. García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073 [No Abstract] [Full Text] [Related]
12. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens. Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059 [TBL] [Abstract][Full Text] [Related]
13. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model. Guinée PA; Jansen WH; Rijpkema SG Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884 [TBL] [Abstract][Full Text] [Related]
14. Cell-wall antigens of V. cholerae and their implication in cholera immunity. Watanabe Y; Ganguly R Prog Drug Res; 1975; 19():612-22. PubMed ID: 1219915 [No Abstract] [Full Text] [Related]
15. Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model. Sharma DP; Thomas C; Hall RH; Levine MM; Attridge SR Vaccine; 1989 Oct; 7(5):451-6. PubMed ID: 2573216 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits. Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096 [TBL] [Abstract][Full Text] [Related]
17. [Vaccination against cholera: what prospects?]. Pierre P; Lucas G; Vaerman JP Ann Soc Belg Med Trop; 1988 Jun; 68(2):83-93. PubMed ID: 3071278 [No Abstract] [Full Text] [Related]
18. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera]. María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578 [TBL] [Abstract][Full Text] [Related]
19. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model. Thungapathra M; Sharma C; Gupta N; Ghosh RK; Mukhopadhyay A; Koley H; Nair GB; Ghosh A Immunol Lett; 1999 Jun; 68(2-3):219-27. PubMed ID: 10424424 [TBL] [Abstract][Full Text] [Related]
20. A one dose experimental cholera vaccine. Muse M; Grandjean C; Wade TK; Wade WF FEMS Immunol Med Microbiol; 2012 Oct; 66(1):98-115. PubMed ID: 22612159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]